OUI's quarterly round up of news and data, plus our year-end stats.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Oxford University spinout Vaccitech will use investment from GV, Oxford Sciences Innovation and Sequoia China to advance a universal flu vaccine and address other diseases requiring cellular immune activation.
Gene therapy spinout Nightstar Therapeutics signs deal with Oxford University Innovation to tackle Stargardt disease.
Oxford University Innovation’s digital health deal with Drayson Technologies and Oxford University Hospitals celebrated at annual OBN awards.
In Q2 2017, Oxford companies raised £93m, OUI was named TTO of the Year, and the £1.2bn contribution to the global economy from Oxford's commercialisation capabilities was highlighted in a new report.